ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 699671 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 699671; 2) Community: the network communities that were significantly associated with the response to NSC 699671; 3) Molecule: the relationships between components within communities and NSC 699671; 4) MDR: the compounds that were significantly associated with the NSC 699671.

NSC Compound Enrichment Correlation
NSC 736780 (2Z,4E)-2-cyano-5-[4-(diethylamino)phenyl]penta-2,4-dienethi oamide 0.0438391811600412 0.41874532
NSC 736793 Null 0.0438391811600412 0.33194966
NSC 744469 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate 0.0438391811600412 0.49573823
NSC 749160 Null 0.0438391811600412 0.45283139
NSC 758359 N3-[1-(3-phenoxybenzyl)-1H-1,2,3-triazol-4-yl]methyl-2-(4-fluoroanilino)nicotinamide 0.0438391811600412 -0.32411489
NSC 90810 Null 0.0438391811600412 0.44367903
NSC 105132 Deoxycamptothecin 0.0438391811600418 0.2579385
NSC 134459 Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) 0.0438391811600418 0.41317157
NSC 134723 K 31 0.0438391811600418 0.21596338
NSC 164970 Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- 0.0438391811600418 0.3826856
Total:119  Current:98    [First] [Prev] [Next] [Last]